Originators in the development of injectable collagenase
Home
About BioSpecifics
BioSpecifics Overview
Leadership
Partnerships
Our Technology
Collagen and Scar Tissue
Collagenase
Therapeutic Use
Intellectual Property
Pipeline
Pipeline
Dupuytren's Contracture
Peyronie's Disease
Adhesive Capsulitis
Lipoma
Cellulite
Uterine Fibroids
Additional Indications
Investors
Stock Information
Stock Quote
Interactive Chart
IR Snapshot
Historical Stock Price
Investment Calculator
Analyst Coverage
Financial Reporting
SEC Filings
Fundamentals
IR Key Ratios
Annual Reports
Corporate Governance
Press Releases
Events and Presentation
FAQs
Email Alerts
Get News Alerts by Email
All RSS Feeds
Contact Us
Contact
Contact Us via Email
Sitemap
View the BioSpecifics 2018 Corporate Presentation
Home
About BioSpecifics
BioSpecifics Overview
Leadership
Thomas L. Wegman, President
Partnerships
Our Technology
Collagen and Scar Tissue
Collagenase
Therapeutic Use
Intellectual Property
Pipeline
Pipeline
Dupuytren's Contracture
Peyronie's Disease
Adhesive Capsulitis
Lipoma
Cellulite
Uterine Fibroids
Additional Indications
Investors
Stock Information
Stock Quote
Interactive Chart
IR Snapshot
Historical Stock Price
Investment Calculator
Analyst Coverage
Financial Reporting
SEC Filings
Fundamentals
IR Key Ratios
Annual Reports
Corporate Governance
Press Releases
Events and Presentation
FAQs
Email Alerts
Get News Alerts by Email
All RSS Feeds
Contact Us
Contact
Contact Us via Email